These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37716514)

  • 1. Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs.
    Tong H; Yang T; Liu L; Li C; Sun Y; Jia Q; Qin Y; Chen L; Zhao X; Zhou G; Yan S; Li XJ; Li S
    Neurobiol Dis; 2023 Oct; 187():106291. PubMed ID: 37716514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis.
    Gipson TA; Neueder A; Wexler NS; Bates GP; Housman D
    RNA Biol; 2013 Nov; 10(11):1647-52. PubMed ID: 24256709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model.
    Veldman MB; Rios-Galdamez Y; Lu XH; Gu X; Qin W; Li S; Yang XW; Lin S
    Mol Neurodegener; 2015 Dec; 10():67. PubMed ID: 26645399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.
    Kaye J; Reisine T; Finkbeiner S
    Fac Rev; 2021; 10():77. PubMed ID: 34746930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.
    Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA
    Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington disease models.
    Sogorb-Gonzalez M; Landles C; Caron NS; Stam A; Osborne G; Hayden MR; Howland D; van Deventer S; Bates GP; Vallès A; Evers M
    Brain; 2024 Aug; ():. PubMed ID: 39155061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
    Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
    J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form.
    Yang H; Yang S; Jing L; Huang L; Chen L; Zhao X; Yang W; Pan Y; Yin P; Qin ZS; Tang B; Li S; Li XJ
    Nat Commun; 2020 May; 11(1):2582. PubMed ID: 32444599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington's Disease and Human Blood Plasma.
    Ananbeh H; Novak J; Juhas S; Juhasova J; Klempir J; Doleckova K; Rysankova I; Turnovcova K; Hanus J; Hansikova H; Vodicka P; Kupcova Skalnikova H
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
    Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
    Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.
    Wang B; Zeng L; Merillat SA; Fischer S; Ochaba J; Thompson LM; Barmada SJ; Scaglione KM; Paulson HL
    Neurobiol Dis; 2018 Jan; 109(Pt A):127-136. PubMed ID: 28986324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
    Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R
    Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons.
    Tian J; Yan YP; Zhou R; Lou HF; Rong Y; Zhang BR
    Neurosci Bull; 2014 Feb; 30(1):74-80. PubMed ID: 24362588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
    Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
    J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiol-disulfide Oxidoreductases TRX1 and TMX3 Decrease Neuronal Atrophy in a Lentiviral Mouse Model of Huntington's Disease.
    Fox J; Lu Z; Barrows L
    PLoS Curr; 2015 Nov; 7():. PubMed ID: 26664998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TFEB in Huntington's Disease.
    Ojalvo-Pacheco J; Yakhine-Diop SMS; Fuentes JM; Paredes-Barquero M; Niso-Santano M
    Biology (Basel); 2024 Apr; 13(4):. PubMed ID: 38666850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
    Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
    Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-modifying enzymes in Huntington's disease.
    Sap KA; Geijtenbeek KW; Schipper-Krom S; Guler AT; Reits EA
    Front Mol Biosci; 2023; 10():1107323. PubMed ID: 36926679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.